MYC deregulation in primary human cancers M Kalkat, J De Melo, KA Hickman, C Lourenco, C Redel, D Resetca, ... Genes 8 (6), 151, 2017 | 373 | 2017 |
MYC protein interactors in gene transcription and cancer C Lourenco, D Resetca, C Redel, P Lin, AS MacDonald, R Ciaccio, ... Nature Reviews Cancer 21 (9), 579-591, 2021 | 179 | 2021 |
OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors LA Jung, A Gebhardt, W Koelmel, CP Ade, S Walz, J Kuper, B von Eyss, ... Oncogene 36 (14), 1911-1924, 2017 | 113 | 2017 |
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis WB Tu, YJ Shiah, C Lourenco, PJ Mullen, D Dingar, C Redel, A Tamachi, ... Cancer cell 34 (4), 579-595. e8, 2018 | 112 | 2018 |
The MYC oncoprotein directly interacts with its chromatin cofactor PNUTS to recruit PP1 phosphatase Y Wei, C Redel, A Ahlner, A Lemak, I Johansson-Åkhe, S Houliston, ... Nucleic acids research 50 (6), 3505-3522, 2022 | 15 | 2022 |
MYC deregulation in primary human cancers. Genes 8 M Kalkat, J De Melo, KA Hickman, C Lourenco, C Redel, D Resetca, ... E151 Medline, 2017 | 6 | 2017 |
Targeting the MYC oncoprotein by disrupting the MYC-PNUTS interaction C Redel University of Toronto (Canada), 2022 | | 2022 |
The PNUTS-PAD domain recruits MYC to the PNUTS: PP1 phosphatase complex via the oncogenic MYC-MB0 region Y Wei, A Ahlner, C Redel, A Lemak, I Johansson-Åkhe, S Houliston, ... bioRxiv, 2021.12. 02.470928, 2021 | | 2021 |
A Report on the Status of Graduate Student Mental Health in the Department of Medical Biophysics S Majeed, J Kelly, T Samuel, N Bragagnolo, C Redel, P Smirnov, ... | | 2020 |